Login

Aram Mangasarian , CEO, NOXXON Pharma 00:00:00

Share On Facebook Share On Twitter

NOXXON PHARMA - Interview with CEO Aram MANGASARIAN

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The New York Stock Exchange welcomes UiPath executives and guests to celebrate its Initial Public Offering (NYSE: PATH).
00:10:00
Powering the Future: Insights from Denis Phares, Dragonfly Energy CEO | Denis Phares - CEO of Dragonfly Energy Corporation
00:00:00
Michael Hunt CFO of ReNeuron Group (RENE) at SHARES Innovators and Investors Forum - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Finding Balance: Betty Wang's Journey to Intentional Success | Betty Wang - CERTIFIED FINANCIAL PLANNER, BW Financial Planning
00:10:00
CEO discusses UK supermarket deal and revenue growth, highlighting shift to nicotine-free vape products and expansion plans for 2024 | Callum Sommerton, CEO, Chill Brands Group PLC.
00:10:00
Long-term Investment Strategies Amid Trade Tensions and Economic Shifts in China | Yimei Li, CEO , China Asset Management.
00:10:00
Investing in and building groundbreaking companies at their best|Ammar Amdani,Managing Partner,Adapt Ventures
00:10:00
Global Market Insights: Punita Kumar Sinha on Growth Opportunities and Sector Valuations | Punita Kumar Sinha, Managing Partner, Pacific Paradigm Advisors and Chairperson, InCred AMC
00:10:00
Tim Brown on Allbirds' Net-Zero Sneaker and Commitment to Sustainability | Tim Brown, Co-Founder, Allbirds Inc.
00:10:00
Strategies to Replace Income from a Sold Investment Property
00:10:00
Treatment of cancer in dogs and neurodegenerative diseases in humans.|Dr Michael Thurn,Chief Executive Officer,PharmAust Ltd
00:10:00
Cemex CEO Takes Helm at Global Cement Association | Fernando Angel Angel Gonzalez Olivieri - CEO of Cemex

© 2026 Nehu